Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)
Crossref DOI link: https://doi.org/10.1007/s00280-014-2499-4
Published Online: 2014-06-18
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dragovich, T.
Laheru, D.
Dayyani, F.
Bolejack, V.
Smith, L.
Seng, J.
Burris, H.
Rosen, P.
Hidalgo, M.
Ritch, P.
Baker, A. F.
Raghunand, N.
Crowley, J.
Von Hoff, D. D.
Text and Data Mining valid from 2014-06-18